Hepatitis C virus acute exacerbation during chemotherapy and radiotherapy for oesophageal carcinoma

Ann Oncol. 1994 Nov;5(9):861-2. doi: 10.1093/oxfordjournals.annonc.a059022.

Abstract

Aims: We report the first case of an hepatitis C virus positive patient presenting with a solid tumor and developing an exacerbation of his hepatitis C after chemotherapy.

Case report: A 56-year-old white male, previously infected with hepatitis C virus and treated for epidermoid carcinoma of the oesophagus, developed hepatitis (alamine aminotransferase 2376 U/l and aspartate aminotransferase 2262 U/l) after chemotherapy with cisplatin and vinblastine.

Methods: Polymerase chain reaction detected hepatitis C virus RNA in the serum during the acute phase, which returned to negative 14 weeks later.

Discussion: Viral replication was probably increased during immunosuppression induced by chemotherapy. Enhanced cellular immune response in the recovery phase was the most likely cause of the hepatitis.

Conclusions: More attention should be paid to liver function tests in patients with a previous history of hepatitis C virus infection. Polymerase chain reaction identification of hepatitis C virus RNA can be a very useful tool that permits rapid diagnosis and appropriate management of such cases.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Carcinoma / complications
  • Carcinoma / drug therapy*
  • Carcinoma / radiotherapy
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Esophageal Neoplasms / complications
  • Esophageal Neoplasms / drug therapy*
  • Esophageal Neoplasms / radiotherapy
  • Hepatitis C / diagnosis
  • Hepatitis C / etiology*
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • RNA, Viral / analysis
  • Vinblastine / administration & dosage

Substances

  • RNA, Viral
  • Vinblastine
  • Cisplatin